OBJECTIVE: Studies of the pathological mechanisms of food allergy have been impeded by the lack of relevant animal models. The purpose of this study was to develop a physiological model of food allergy that was not dependent on immunostimulatory adjuvants. MATERIAL AND METHODS: Balb/c mice were epicutaneously sensitized four times at varying intervals over a 22-day period, and challenged orally from day 40, 6 times every 1-3 days with either saline or ovalbumin. RESULTS: After sensitization (day 35) but before the oral challenges, the ovalbumin-sensitized groups showed increased specific IgE and IgG1 production when compared with the sham-sensitized groups. Mucosal mast cell protease-1 (MMCP-1) was undetectable in serum before the intragastric challenge. MMCP-1 concentrations were increased after the first ovalbumin dose, solely in the ovalbumin-sensitized and -challenged group. After the challenge period, the mean serum MMCP-1 concentration increased from an undetectable level in controls to an over 44-fold level in the ovalbumin-sensitized and -challenged mice. In this group, MMCP-1-positive cells were present in the small intestine and expressions of IFN-gamma and CXCL-9 mRNA were decreased in the ileum, suggesting an impaired Th-1-type response. Within one hour of the last ovalbumin challenge, 5 out of 6 mice developed diarrhea in the ovalbumin-sensitized and -challenged group, but there was no diarrhea in the other groups. CONCLUSIONS: A murine model of food allergy based on sensitization via epicutaneous exposure to allergen without immunostimulatory adjuvants was developed. Effective production of MMCP-1 together with specific IgE and IgG1 suggests a breakdown in oral tolerance to the allergen. Intragastric challenges were accompanied by mast cell-dependent immunopathological changes and diarrhea.
OBJECTIVE: Studies of the pathological mechanisms of food allergy have been impeded by the lack of relevant animal models. The purpose of this study was to develop a physiological model of food allergy that was not dependent on immunostimulatory adjuvants. MATERIAL AND METHODS: Balb/c mice were epicutaneously sensitized four times at varying intervals over a 22-day period, and challenged orally from day 40, 6 times every 1-3 days with either saline or ovalbumin. RESULTS: After sensitization (day 35) but before the oral challenges, the ovalbumin-sensitized groups showed increased specific IgE and IgG1 production when compared with the sham-sensitized groups. Mucosal mast cell protease-1 (MMCP-1) was undetectable in serum before the intragastric challenge. MMCP-1 concentrations were increased after the first ovalbumin dose, solely in the ovalbumin-sensitized and -challenged group. After the challenge period, the mean serum MMCP-1 concentration increased from an undetectable level in controls to an over 44-fold level in the ovalbumin-sensitized and -challenged mice. In this group, MMCP-1-positive cells were present in the small intestine and expressions of IFN-gamma and CXCL-9 mRNA were decreased in the ileum, suggesting an impaired Th-1-type response. Within one hour of the last ovalbumin challenge, 5 out of 6 mice developed diarrhea in the ovalbumin-sensitized and -challenged group, but there was no diarrhea in the other groups. CONCLUSIONS: A murine model of food allergy based on sensitization via epicutaneous exposure to allergen without immunostimulatory adjuvants was developed. Effective production of MMCP-1 together with specific IgE and IgG1 suggests a breakdown in oral tolerance to the allergen. Intragastric challenges were accompanied by mast cell-dependent immunopathological changes and diarrhea.
Authors: Baodong Sun; Michael D Kulis; Sarah P Young; Amy C Hobeika; Songtao Li; Andrew Bird; Haoyue Zhang; Yifan Li; Timothy M Clay; Wesley Burks; Priya S Kishnani; Dwight D Koeberl Journal: Mol Ther Date: 2009-08-18 Impact factor: 11.454
Authors: Mario Noti; Brian S Kim; Mark C Siracusa; Gregory D Rak; Masato Kubo; Amin E Moghaddam; Quentin A Sattentau; Michael R Comeau; Jonathan M Spergel; David Artis Journal: J Allergy Clin Immunol Date: 2014-02-20 Impact factor: 10.793
Authors: Jørgen Valeur; Jani Lappalainen; Hannu Rita; Aung Htun Lin; Petri T Kovanen; Arnold Berstad; Kari K Eklund; Kirsi Vaali Journal: BMC Gastroenterol Date: 2009-05-18 Impact factor: 3.067
Authors: Claire Galand; Juan Manuel Leyva-Castillo; Juhan Yoon; Alex Han; Margaret S Lee; Andrew N J McKenzie; Michael Stassen; Michiko K Oyoshi; Fred D Finkelman; Raif S Geha Journal: J Allergy Clin Immunol Date: 2016-06-02 Impact factor: 10.793